Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CVS Group plc ( (GB:CVSG) ) just unveiled an announcement.
CVS Group plc reported a 6.6% increase in sales to £341.8m for the first half of 2025, despite facing softer market conditions in the UK. The company is focusing on growth in Australia due to the stable regulatory environment, completing five acquisitions. Adjusted EBITDA rose by 4.5%, and the company aims to offset anticipated UK cost increases through efficiencies and synergies. The Healthy Pet Club scheme membership grew, and the company invested £16.8m in infrastructure and technology. Despite the UK’s regulatory challenges, CVS remains confident in meeting its full-year expectations.
More about CVS Group plc
CVS Group plc is an AIM-listed provider of veterinary services, operating in the UK and Australia. The company focuses on delivering high-quality clinical services with a dedicated team, operating approximately 460 veterinary practices, including specialist referral hospitals and out-of-hours sites. CVS also runs laboratories, crematoria, and an online retail business, employing around 9,000 personnel, including 2,400 veterinary surgeons and 3,300 nurses.
YTD Price Performance: 22.62%
Average Trading Volume: 312,259
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £723.1M
See more insights into CVSG stock on TipRanks’ Stock Analysis page.
